2028, Pharmacokinetics and Small Molecule

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2028

Pharmacokinetics

Small Molecule

Highs and lows of drug repurposing

Drug Discovery World

SEPTEMBER 26, 2022

It’s also why pharmaceutical companies will look to acquire smaller biotechs and drug discovery companies, because a lot of the legwork into finding a suitable molecule for a disease has already been done. . This level of growth is unsurprising for an industry which will always look to the latest opportunities to drive science. .

Pharmaceutical Companies

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials

Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas

The Pharma Data

SEPTEMBER 15, 2020

27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. Phase 1 data and development plans for danuglipron (PF-06882961), which has the potential to be the first-ever small molecule oral GLP-1RA for treating obesity and type 2 diabetes.

Vaccine

Vaccine Therapies Trials Clinical Trials

Drug Discovery Digest

Highs and lows of drug repurposing

Pfizer Investor Day Features Significant Number of Pipeline Advances for COVID-19 Programs and Across Numerous Therapeutic Areas

Stay Connected